Study Objectives: Cross-sectional studies suggest that insomnia symptoms are associated with falls in later life. This longitudinal study examines the independent and interactive effects of the extent of insomnia symptoms (i.e., multiple co-existing insomnia symptoms) and sleep medications on fall risk over a 2-year follow-up among community-dwelling older adults. Methods: Using data from the Health and Retirement Study (2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014), N = 6882, M age = 74.5 years ± 6.6 years), we calculated the extent of insomnia symptoms (range = 0-4) participants reported (i.e., trouble falling asleep, waking up during the night, waking up too early, and not feeling rested). At each wave, participants reported recent sleep medications use and falls since the last wave, and were evaluated for balance and walking speed. Results: A greater burden of insomnia symptoms and using physician-recommended sleep medications at baseline independently predicted falling after adjusting for known risk factors of falling. The effects of insomnia symptoms on fall risk differed by sleep medications use. The extent of insomnia symptoms exhibited a positive, dose-response relation with risk of falling among those not using sleep medications. Older adults using physician-recommended sleep medications exhibited a consistently higher fall risk irrespective of the extent of insomnia symptoms.
INTRODUCTION
Falls are a major health concern among older adults. Over 30% of community-dwelling adults aged 65 years and older fall every year. 1 Falls among older adults can result in injuries, impaired physical functioning (e.g., poor balance) and psychological functioning (e.g., depression), and a poorer health-related quality of life. [2] [3] [4] Moreover, the annual cost for falls in the older population was estimated to be about US $23.3 billion in the United States. 5 Therefore, it is imperative to identify factors that cause falls and initiate appropriate intervention to prevent future falls.
Older adults with sleep problems may be susceptible to falling. Research has shown that sleep problems (e.g., abnormal sleep hours and insomnia) are associated with several risk factors of falls, 1 such as increased pain experience, 6 depressive symptoms, 7, 8 functional limitations, 7 slower reaction time, 9, 10 cognitive performance, 11 and physical functions (e.g., postural control and walking speed). 12 As about 50% of community-dwelling older adults report at least one sleep problem, 7, 13 examining the relationship between sleep problems and falls will guide us toward one potential component of future preventive interventions aiming to decrease falls in later life.
Previous longitudinal studies have identified diverse sleep problems that may relate to falls among older adults. 9, [14] [15] [16] [17] Specifically, studies found that falls were associated with habitual sleep duration <7 hours per night relative to 7-8 hours of sleep (measured by wrist actigraphy or self-report hours), 9, 14, 15 napping during the day (self-report), 9, 16 daytime sleepiness (measured by the Epworth Sleepiness Scale), 15 being awake for more than 120 minutes after sleep onset (measured by wrist actigraphy), 14 poor sleep quality while using sleep medications (measured by the Pittsburgh Sleep Quality Index and medication review), 17 and poor sleep efficiency (measured by wrist actigraphy). 14, 15 Moreover, insomnia symptoms are a significant burden for older adults that may increase future health risks, including falls. Several cross-sectional studies found that insomnia symptoms, such as trouble falling asleep, waking up during the night, waking up too early, and not feeling rested, [18] [19] [20] were associated with falls among older adults.
To date, however, no longitudinal study has investigated the association of insomnia symptoms with falls among community-dwelling older adults. A longitudinal relationship between insomnia and falls has been observed in residents in nursing homes. 21 Another study led by the same author excluded individuals in nursing homes, 22 but the outcome was a combination of any accidental event (e.g., falls, cutting/piercing, and electrocution). Whether insomnia specifically relates to falls longitudinally in community-dwelling older adults is unclear.
Older adults often have co-existing insomnia symptoms. 7 Examining multiple co-existing insomnia symptoms may
Statement of Significance
Reporting a greater extent of insomnia symptoms independently increases the risk of falling among older adults. The extent of insomnia symptoms exhibits a dose-response relation with fall risk among individuals not using sleep medications. Older adults using physician-recommended sleep medications exhibit a consistently higher fall risk irrespective of their baseline number of insomnia symptoms and at any number of insomnia symptoms (from none to four symptoms). Treating insomnia while carefully selecting and closely monitoring the use of sleep medications may help reduce future falls in older adults.
capture more fragmented sleep and longer waking time when a person is supposed to sleep. However, previous studies primarily focused on understanding the associations of the presence of insomnia or a single insomnia symptom report with falls. 17, 19, 20 Whether older adults experiencing a greater number of insomnia symptoms are at a higher risk of falling is unknown. Moreover, prior studies 17, 19, 20 did not take into account potentially confounding effects of older adults' physical performance (e.g., balance and walking speed) that may contribute to falls. 1 Another aspect that is not clear is the role of sleep medications in the longitudinal relationship between the extent of insomnia symptoms and the risk of falling in older adults. Although physician-recommended sleep medications may result in adverse effects (e.g., ataxia or residual sedation) 23, 24 or indicate experiencing sleep problems and thus may relate to increased risk of falling, [25] [26] [27] sleep medications may relieve insomnia symptoms among older adults 24 and could potentially reduce the risk of falling subsequently.
The current study examined the longitudinal association between multiple co-existing insomnia symptoms and falls, drawing upon data from a nationally representative sample of community-dwelling older adults in the United States. We hypothesized (H1) that older adults who had a greater number of insomnia symptoms at baseline would have an increased likelihood of falling in the future. Additionally, we hypothesized (H2) that older adults who used physician-recommended sleep medications would have an increased likelihood of having a fall in the future independent of the number of insomnia symptoms, physical performance, and other known risks of falling. Our third research question asked whether the use of physician-recommended sleep medications moderated the effect of the extent of insomnia symptoms on falls. We hypothesized (H3) that the impact of a great number of insomnia symptoms on fall risk would be different between individuals used physician-recommended sleep medications and those who did not use sleep medications. We did not expect to find this difference between using nonphysician-recommended sleep medications group and no medications group.
METHODS

Data
This study used data from the Health and Retirement Study (HRS). The HRS is an ongoing longitudinal study. Participants were interviewed every 2 years since 1992. A multi-stage sampling strategy was performed. African Americans, Hispanics, and residents in Florida were oversampled. The HRS contains rich data related to family, health, income, and retirement among older adults and is suitable for answering various research questions. Details about the HRS can be found in the report by Heeringa and Connor. 28 Because objective clinically evaluated balance and walking measures were first available in 2006 in the HRS, 29 we used all available data from wave 2006 to 2014.
Measures
Any Fall
During the HRS interview, participants were asked "Have you fallen down since previous wave (or in the last 2 years)?" Response options were yes (1) or no (0).
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Extent of Insomnia symptoms
In the HRS, participants were asked how often they had trouble with "falling asleep," "waking up during the night," and "waking up too early and not being able to fall asleep again." They were also asked how often they felt "really rested when wake up in the morning." The responses to these four questions were "most of the time," "sometimes," and "rarely or never." Following the coding methods used in previous studies, 32, 33 four dummy variables were created. For the first three items, "Most of the time" and "sometimes" were coded as 1 (having these symptoms). For the fourth item, "sometimes" and "rarely or never" were coded as 1 so that 1 indicated not feeling rested in the morning. A composite score (0-4) for the number of insomnia symptoms was created. A higher score reflected a greater burden of insomnia symptoms.
Sleep Medications
The HRS asked participants whether they had taken any medications or used other treatment to help them sleep in the past 2 weeks. If individuals reported that they had used sleep medications, they were further asked whether a doctor "recommended" the sleep medications or treatment. A categorical variable was created with three levels: no medications (reference group), nonphysician-recommended medications (or treatment), and physician-recommended medications (or treatment).
Covariates
Several known risk factors for falls were included as covariates. 1 For social-demographic characteristics, age and education were measured in years. Sex and race were dummy-coded with women and White coded as 1. Regarding the balance test, 29, 34 participants were first asked to hold a semi-tandem stance for 10 seconds. If participants successfully completed the semi-tandem stance, they were asked to maintain a full-tandem stance for 30 seconds. If participants failed to complete the semi-tandem stance, they were asked to hold a side-by-side stance for 10 seconds. A categorical variable was created with four levels: complete full-tandem (reference group), complete semi-tandem, complete side-by-side, and cannot complete side-by-side. A timed walking test 29, 34 was administered by asking participants to walk a 2.5-m course twice (go and back; 5 meters in total). The average time (in seconds) to complete the walking test was used in the analyses. Information about the self-rated vision was also included in this study. Participants were asked to rate their eyesight on a 5-point scale (1 = excellent, 2 = very good, 3 = good, 4 = fair, or 5 = poor) when using glasses or corrective lenses.
Study Design
Following the analytical strategy used by Himes and Reynolds, , and 2014 served as follow-up, respectively. This strategy is effective to maximize the use of existing data, especially when studying a rare event, such as falls. The overview of our study design and exclusion flow diagram is shown in Figure 1 . Among 152 740 total observations pooled across the four 2-yr intervals, those who were younger than 65 years of age, answered question by a proxy, did not live in community, and did not provide information on sleep, falls, and physical measures were excluded from the analyses. HRS documented the reasons for the missingness for physical measures (i.e., balance test and walking test). These reasons included respondents (or interviewers) thought the tests would not be safe, respondents refused, did not understand the instruction, could not stand due to surgery, injury or health condition, or there was no suitable place for the tests. Additionally, the HRS only asked new participants (but not existing participants) in waves 2008 and 2012 on three insomnia symptoms questions about "falling asleep," "waking up during the night," and "waking up too early and not being able to fall asleep again." Thus, new participants were able to provide responses on all the four items of insomnia symptoms, but existing participants were not. As this study focused on the total number of insomnia symptoms summing responses on all the four insomnia items, we had to exclude insomnia symptom observations in 2008 and 2012 from existing participants. The final sample included 6 882 observations (from 4 669 participants). This sample had an average age of 74.5 years (SD = 6.6) at baseline and was mostly White (85.7%) and women (57.4%; see overall column in Table 1 ), a similar demographic composition compared with national norms 35 and previous studies.
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Statistical Analyses
Descriptive analyses were used to explore participants' characteristics based on falls status at baseline. Univariate logistic regression analyses were performed to assess the associations of the extent of insomnia symptoms, sleep medications, and covariates at baseline with falls at follow-up. 14, 36 Significant variables related to falls in the univariate logistic regression model were then entered into a multivariate logistic regression model to examine the effects of the extent of insomnia symptoms at baseline on falls at follow-up, first adjusting for sleep medications (Model 1) and then adjusting for significant covariates found in the univariate logistic regression analyses (Model 2). Next, the interaction effect between the extent of insomnia symptoms and sleep medications at baseline on the falls at follow-up was investigated. When modeling falls at follow-up, we controlled for falls at baseline to examine whether the extent of insomnia symptoms or sleep medications predicted changes in the likelihood of falls during the given 2-years' time period. The impact of each insomnia symptom on the falls was also assessed. The results were displayed as odds ratio (OR) and 95% confidence interval (95% CI). Data were analyzed with SPSS version 22.
RESULTS
At baseline, 32% of the participants fell at least once in the past 2 years, and at follow-up, 34% of participants reported at least one fall in the prior 2 years. Participants' characteristics based on falls outcomes at baseline are displayed in Table 1 . In general, older adults who fell reported a greater number of insomnia symptoms compared with those who did not fall. Additionally, a higher percentage of older adults who fell used nonphysician-recommended or physician-recommended sleep medications than those did not fall. Participants who fell were older and had poorer balance, walking speed, and vision than those who did not fall. The percentage of women and White participants were higher among those who reported at least one fall compared with those who did not report any fall. The correlation between variables can be found in supplementary table S1. Table 2 shows the results from univariate logistic regression analyses examining the relationships between each predictor at baseline and any fall at follow-up. Significant factors at baseline related to any fall at follow-up were the extent of insomnia symptoms, using physician-recommended sleep medications, age, sex, race, any fall, balance, walking speed, and vision. In the next set of analyses, we examined the effects of the extent of insomnia symptoms and sleep medications at baseline on any fall at follow-up adjusting for significant covariates found in the univariate analyses. Table 3 shows the results from the multivariate logistic regression model predicting the likelihood of falling at follow-up. Model 1 showed that the extent of insomnia symptoms and using physician-recommended sleep medications at baseline were significant predictors of any fall at follow-up. That is, independent of sleep medications, experiencing a greater number of insomnia symptoms predicted higher odds of falling in the future. Moreover, compared with no sleep medications, using physician-recommended sleep medications increased the likelihood of falling independent of the extent of insomnia symptoms. Model 2 adjusted for age, any fall, balance, walking speed, and vision at baseline and sex and race. The effects of the extent of insomnia symptoms and using physician-recommended sleep medications at baseline remained significant. Specifically, older adults who reported one additional insomnia symptom at baseline were 5% more likely to fall at follow-up (H1 supported). Compared with older adults who did not use sleep medications, those who used physician-recommended sleep medications at baseline were approximately 34% more likely to report a fall at follow-up (H2 supported). There was no significant effect of using nonphysician-recommended sleep medications (vs. no medications) on any fall. We conducted supplementary analyses to see whether these associations differed by older adults' physical performance (i.e., balance and walking speed). There were no significant interactions of the extent of insomnia symptoms or sleep medications with each of the physical performance measures (results are not shown, but available upon request). Thus, the effects of the extent of insomnia symptoms and sleep medications on falls held across different levels of performance on balance and walking tests.
Independent Effects of the Extent of Insomnia Symptoms and Sleep Medications on Future Fall Risk
' Characteristics by the Status of Falls at Baseline (n = 6882).
Moderating Effect of Physician-Recommended Sleep Medications On the Impact of the Extent of Insomnia Symptoms on Future Fall Risk
The results of the interactive effects showed that the impact of the extent of insomnia symptoms on future fall risk was significantly different for participants using physician-recommended sleep medications, compared with no medications. No significant difference was found for nonphysician-recommended sleep medications (H3 supported). Figure 2 depicts the main effect of the extent of insomnia symptoms on fall risk (Figure 2, A) , as well as the moderating effect of physician-recommended sleep medications on the association of the extent of insomnia symptoms with risk of falling (Figure 2, B) . As the main effect of the extent of insomnia symptoms indicated, the probability of falling at follow-up was amplified with every additional insomnia symptom at baseline (Figure 2, A) . However, such an effect was different between those using physician-recommended sleep medications and those who did not use sleep medications. The extent of insomnia symptoms exhibited a dose-response relation with falls in those who did not take any sleep medication (Figure 2 , B). Compared with participants who did not take any sleep medications, the probability of falling was consistently higher for all levels of insomnia symptoms among older adults who took physician-recommended sleep medications at baseline (Figure 2, B) . Note that the moderating effect was found after adjusting for the effect of any fall at baseline and other covariates.
In sensitivity analyses, we tested whether each individual insomnia symptom predicted any fall, adjusting for sleep medication and significant covariates (Table 4) . Overall, endorsing each of the four items tended to increase the risk of falling, but only not feeling rested when waking up in the morning reached statistical significance.
DISCUSSION
This study examined the independent and interactive effects of the number of insomnia symptoms and sleep medications predicting fall risk among community-dwelling older adults. We found that experiencing a greater number of insomnia 
OR (95%CI)
The extent of insomnia symptoms (0-4) symptoms and taking physician-recommended sleep medications each independently predicted the risk of falling 2 years later, adjusting for other known risk factors of falling (i.e., age, sex, race, and baseline falls, balance, walking speed, and vision). These independent effects of the extent of insomnia symptoms and sleep medications indicate that each explains unique variance in the future risk of falling. The number of insomnia symptoms exhibited a significant dose-response relationship with future 2-year fall risk in older adults who did not use any sleep medication. In contrast, older adults who used physician-recommended sleep medications exhibited a consistently higher probability of falling at all levels of insomnia symptoms (from none to four symptoms). Our results suggest that treating insomnia while carefully selecting and closely monitoring the use of sleep medications may help reduce future falls in older adults. By testing the impact of multiple co-existing insomnia symptoms on future fall risk and the role of sleep medications, our study adds new knowledge on sleep and health in the population of older adults. The use of a nationally representative sample of community-dwelling older adults and a longitudinal design, and the statistical control of clinically evaluated physical performance and other known risk factors of falling increase the validity of our findings.
The Extent of Insomnia Symptoms Increases the Risk of Falling Independent of Known Risk Factors
Our findings contribute to the literature by demonstrating that experiencing a greater burden of insomnia symptoms increases the probability of falling longitudinally. We estimated how the extent of insomnia symptoms at baseline predicted changes in the likelihood of falling at follow-up by controlling for any fall at baseline, which gives higher confidence in interpreting the extent of insomnia symptoms as a predictor of having a fall in the future. Although the effect size of insomnia symptoms was not large compared with prior history of a fall, the effect was observed after controlling for prior experience of falls, the strongest predictor of future falls in many studies. 1 That is, the extent of insomnia symptoms explained additional variance in future falls that prior falls did not explain. Furthermore, we adjusted for the effects of sociodemographic characteristics and objective physical performance (balance and walking speed) and thus corroborate the unique prediction of the extent of insomnia symptoms beyond other known risk factors of future falls.
Building on previous work that tested the association of single insomnia symptom with falls, 19, 20 this study examined the extent of insomnia symptoms (i.e., the total number of insomnia symptoms) that can capture co-existing insomnia symptoms prevalent in the elderly. 7 Multiple insomnia complaints are common among older adults, 7 and our findings suggest that investigating a single insomnia symptom may underestimate the impact of multiple co-existing insomnia symptoms on fall risk (Table 4) . It is possible that older adults with a greater number of insomnia symptoms are not well rested and experience greater tiredness and drowsiness compared with those with no or fewer insomnia symptoms. Subsequently, they may fall because of slower reaction to correct their balance while standing or walking. 10, 12, 13 Unfortunately, other sleep variables or problems such as sleep hours, daytime sleepiness, daily napping, and sleep apnea are not available in the HRS, a limitation of the current analysis. Future studies could investigate whether and how other sleep characteristics and co-existing sleep problems contribute to the relationship between the extent of insomnia symptoms and falls.
Use of Physician-Recommended Sleep Medications Moderates the Effects of the Extent of Insomnia Symptoms on Future Fall Risk
Thus far, few studies have reported how sleep medication use impacts the relationship between insomnia symptoms and falls. Our findings revealed both main effects and moderating effects of sleep medications. With regard to its main effect, at all levels of insomnia symptoms (from none to four symptoms), taking physician-recommended sleep medications at baseline was associated with a greater fall risk relative to not taking any sleep medication. However, the role of physician-recommended sleep medications differed in the relationship between the extent of insomnia symptoms and falls. Older adults who did not use any sleep medication exhibited increased probability of falling with the increase in every number of insomnia symptoms; for older adults who used physician-recommended sleep medications, a consistent elevated risk of falling was observed across all levels of insomnia symptoms. Our findings suggest that using physician-recommended sleep medications can impose additional risk of falling above and beyond insomnia symptoms burden. Physician-recommended sleep medications may cause side effects (e.g., ataxia or residual sedation) that can affect older adults' balance. 23, 24 Alternatively, older adults using physician-recommended sleep medication may have some greater insomnia symptom burden that is not captured by the simple symptom self-report. Note that using sleep medications that were not recommended by doctors did not seem to predict falling or moderate the effect of the extent of insomnia symptoms on any fall. Future research should examine the specific kinds of nonphysician-recommended sleep medications the older adults commonly use and track the side effects of those medications, especially for falls and other future health risks.
Practical Implications
Sleep problems are not necessarily a part of normal aging, 37 but they are more common among older adults and often undertreated. 7, 38 Insomnia is related to a poorer health status 39 and may aggravate the underlying health conditions, 40 which can subsequently lead to a higher rate of hospitalization 32 and medications use. 33 Previous research has contributed to our understanding of several nonmodifiable and modifiable risk factors of falls. [2] [3] [4] For example, a history of falling, age, and gender are nonmodifiable markers. To prevent falls, the best strategy is to reduce modifiable risk factors. 1 Given that insomnia symptoms and the use of sleep medications are significant predictors of falls and can be successfully managed, [41] [42] [43] targeting these two factors may subsequently reduce the probability of falling.
Of clinical concern, older adults have an increased risk of falling, within a 2-year follow-up period, directly proportional to their self-reported extent of insomnia symptoms controlling for clinical evaluations of fall risk such as gait and walking speed. Falls occurred at high rates in older adults taking physician-recommended sleep medication. It is, therefore, important for clinicians to screen older adults for the presence of insomnia and make a referral to a specialist in sleep disorders if needed. Clinicians are recommended to prefer cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment in cognitively competent older adults. 41 CBT-I has been found to be effective in treating insomnia among older adults and in sustaining the effects longer compared with sleep medications or other treatments (e.g., Tai Chi exercise) 42, 43 with potentially fewer side effects for falls. If CBT-I is unsuccessful, clinicians are then recommended to discuss with the patients the benefits and risks of short-term use of pharmacological therapy before prescribing sleep medications. 41 It is also worthy to note that, in our study, there were individuals who reported no insomnia symptoms, but used physician-recommended (n = 44) or nonphysician-recommended (n = 33) sleep medications. This situation was also found in a previous cross-sectional study. 18 Such an observation suggests that older adults may have used sleep medications to relieve their insomnia symptoms and continue to use the medications even after their insomnia symptoms have resolved. This is important because our findings showed that older adults who used physician-recommended sleep medications appeared to have a higher probability of falling compared with those who did not use sleep medications, regardless of the extent of insomnia symptoms endorsed (Figure 2, B) . In the previous study, the researchers also found associations of single falls and injurious falls with individuals who did not have any insomnia symptoms but used sleep medications. 18 A better medications review and planned medications withdrawal may help reduce falls. 44 
Limitations and Future Directions
There are limitations in this current study. First, there may be recall bias because older adults retrospectively reported about falls happened in the last 2 years. The circumstances of falls were not collected in the HRS; we would, otherwise, be able to examine whether, for example, older adults fell during nocturnal walking or fell because of cognitive impairment. Future research is also recommended to examine the impact of the extent of insomnia symptoms on recurrent falls. Researchers have noted that recurrent falls are likely to be due to intrinsic risks (e.g., poor balance), rather than extrinsic risks (e.g., environment). 30, 36, 45 Experiencing a greater burden of insomnia symptoms may relate to intrinsic risks of older adults 10 and hence may predict recurrent falls. Second, the HRS asked the frequency of each insomnia symptom that participants habitually experienced, but did not specify a time frame (e.g., in the past 6 months). It is possible that individuals may interpret the questions differently. Future studies should specify the time frame in the questionnaires. Third, the HRS asked whether individuals used sleep medications in the past 2 weeks. We, therefore, are unable to know whether individuals have used sleep medications for a longer period of time. Moreover, the use of retrospective survey data may involve recall bias or bias in interpreting correctly the meaning of a "sleep medication." 46 Furthermore, information on specific sleep medications was not available in the HRS which instead simply delineated whether recommended by a physician. Future research may benefit from incorporating more specific or valid information via a sleep medications diary, or electronic health records, to fully understand the effects of sleep medications on falls among older adults.
CONCLUSIONS
Findings from the current study provide strong evidence that the extent of insomnia symptoms (i.e., experiencing multiple co-existing insomnia symptoms) and the use of physician-recommended sleep medications independently predict increased risk of future falls among community-dwelling older adults. Moreover, using physician-recommended sleep medications can impose extra risk of falling above and beyond the extent of insomnia symptoms. Future work will need to further clarify the specific sleep medications contributing to the risk of falls, as well as risk evaluation strategies, to prevent and reduce falls in older adults-a population that their healthy functioning is our best interests.
